BPC-157 is currently in phase II clinical trials for the treatment of IBD
As a general clinical principle: Retest HbA1c no sooner than three months after commencing B12 replacement therapy, and ideally once haematological recovery has been confirmed Confirm haematological recovery normalisation of MCV and haemoglobin before interpreting the repeat HbA1c as reliable Use interim glucose monitoring such as fasting plasma glucose, OGTT, or self-monitored blood glucose (SMBG) to assess glycaemic control during the treatment period
Because fish oil is a supplement and not a drug, it is not rated by the FDA
Most peptides, especially shorter ones, can be preserved for weeks if careful
These include the severity of your vitamin B12 deficiency, your unique needs, and your bodys absorption capacity
Everything else, semaglutide, mazdutide , survodutide , tirzepatide, retatrutide, works through some combination of incretin receptors